{"result": "(\"entity\"<|>DANIEL A. DE LUIS ROMÁN<|>PERSON<|>Dr. Daniel A. de Luis Román is the scientific director and head of the Endocrinology and Nutrition Service at Hospital Clínico Universitario de Valladolid, and he is also a professor at the University of Valladolid.)\n##\n(\"entity\"<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>ORGANIZATION<|>Hospital Clínico Universitario de Valladolid is a medical institution where Dr. Daniel A. de Luis Román works as the head of the Endocrinology and Nutrition Service.)\n##\n(\"entity\"<|>UNIVERSIDAD DE VALLADOLID<|>ORGANIZATION<|>Universidad de Valladolid is the university where Dr. Daniel de Luis Román is a professor of Endocrinology and Nutrition.)\n##\n(\"entity\"<|>PERSAN FARMA<|>ORGANIZATION<|>PERSAN FARMA is a laboratory that sponsored clinical case conferences related to nutrition and diabetes in Spain.)\n##\n(\"entity\"<|>CASTILLA Y LEÓN<|>GEO<|>Castilla y León is a region in Spain where clinical case conferences on diabetes and nutrition were held.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 2<|>EVENT<|>Diabetes Mellitus Tipo 2 is a significant health issue in Spain, with a prevalence of 13.8% in the general population.)\n##\n(\"entity\"<|>ANA ISABEL SÁNCHEZ MARCOS<|>PERSON<|>Dra. Ana Isabel Sánchez Marcos is a specialist in Endocrinology and Nutrition, working in the Eating Disorders Unit at the Complex Health Care University of Salamanca.)\n##\n(\"entity\"<|>COMPLEJO ASISTENCIAL UNIVERSITARIO DE SALAMANCA<|>ORGANIZATION<|>The Complex Health Care University of Salamanca is the institution where Dra. Ana Isabel Sánchez Marcos works in the Eating Disorders Unit.)\n##\n(\"entity\"<|>TRASTORNO DEL COMPORTAMIENTO ALIMENTARIO<|>EVENT<|>Trastorno del Comportamiento Alimentario refers to eating disorders that are prevalent among young women with diabetes type 1.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 1<|>EVENT<|>Diabetes Mellitus Tipo 1 is a chronic condition that affects insulin production and is associated with a higher risk of eating disorders in young women.)\n##\n(\"relationship\"<|>DANIEL A. DE LUIS ROMÁN<|>HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID<|>Dr. Daniel A. de Luis Román is the head of the Endocrinology and Nutrition Service at Hospital Clínico Universitario de Valladolid<|>9)\n##\n(\"relationship\"<|>DANIEL A. DE LUIS ROMÁN<|>UNIVERSIDAD DE VALLADOLID<|>Dr. Daniel A. de Luis Román is a professor at Universidad de Valladolid<|>8)\n##\n(\"relationship\"<|>DANIEL A. DE LUIS ROMÁN<|>PERSAN FARMA<|>Dr. Daniel A. de Luis Román participated in clinical case conferences sponsored by PERSAN FARMA<|>5)\n##\n(\"relationship\"<|>DANIEL A. DE LUIS ROMÁN<|>CASTILLA Y LEÓN<|>Dr. Daniel A. de Luis Román conducted clinical case conferences in Castilla y León<|>5)\n##\n(\"relationship\"<|>ANA ISABEL SÁNCHEZ MARCOS<|>COMPLEJO ASISTENCIAL UNIVERSITARIO DE SALAMANCA<|>Dra. Ana Isabel Sánchez Marcos works in the Eating Disorders Unit at the Complex Health Care University of Salamanca<|>9)\n##\n(\"relationship\"<|>ANA ISABEL SÁNCHEZ MARCOS<|>TRASTORNO DEL COMPORTAMIENTO ALIMENTARIO<|>Dra. Ana Isabel Sánchez Marcos specializes in treating patients with eating disorders<|>8)\n##\n(\"relationship\"<|>ANA ISABEL SÁNCHEZ MARCOS<|>DIABETES MELLITUS TIPO 1<|>Dra. Ana Isabel Sánchez Marcos addresses the challenges of eating disorders in patients with Diabetes Mellitus Tipo 1<|>7)\n##\n(\"relationship\"<|>DANIEL A. DE LUIS ROMÁN<|>DIABETES MELLITUS TIPO 2<|>Dr. Daniel A. de Luis Román discusses the prevalence and management of Diabetes Mellitus Tipo 2<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ):23-36.\n\n14. Alish CJ, Garvey WT, Maki KC, Sacks GS, Hustead DS, Hegazi RA,et al. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther 2010;12:419-25.\n\n15. Alejandro Sanz-París, Diana Boj-Carceller, Beatriz Lardies-Sanchez, Leticia Perez-Fernández and Alfonso J. Cruz-Jentoft. Health-Care Costs, Glycemic Control and Nutritional Status in Malnourished Older Diabetics Treated with a Hypercaloric Diabetes-Specific Enteral Nutritional Formula. Nutrients. 2016 Mar 9; 8:153.\n\n16. ELia M, Ceriello A, heiner laube, alan j. sinclair, meike engfer, rebecca j. stratto. Enteral Nutritional Support and Use of Diabetes-Specific Formulas for Patients With Diabetes:A systematic review and meta-analysis. Diabetes Care 2005, 28(9)2267-89).\n---\n# MESA REDONDA DE CASOS CLÍNICOS, CASTILLA Y LEÓN.\n\nDr. Daniel A. de Luis Román.\nDirector científico.\nJefe del Servicio de Endocrinología y Nutrición.\nHospital Clínico Universitario de Valladolid.\n\n## CASOS CLÍNICOS:\n\nTrastorno del comportamiento alimentario en paciente DM1.\nDra. Ana Isabel Sánchez Marcos..................................................................81\n\nManejo nutricional del paciente diabético con pancreatitis aguda... Ningún\ndía es igual a otro.\nDra. Estefanía Santos Mazo.........................................................................92\n\n79\n---\n# Casos clínicos de nutrición y diabetes mellitus tipo 2\n\n## Prof. Dr. Daniel de Luis Román\n\nCatedrático de Endocrinología y Nutrición. Universidad de Valladolid.\nJefe de Servicio de Endocrinología y Nutrición.\nHospital Clínico Universitario de Valladolid.\nDirector del Área de Ciencias de la Salud adscrito al Rector Uva.\nDirector del Centro de Investigación de Endocrinología y Nutrición.\nFacultad de Medicina. Valladolid.\nwww.ienva.org\nPresidente de la Scledyn.\n\nEn la actualidad la diabetes mellitus tipo 2 (DM2) es un problema de primer orden, por ejemplo, en España se estima una prevalencia en población general del 13,8%, con un 6% de los pacientes que no conocen que padecen esta enfermedad. Por otra parte la desnutrición relacionada con la enfermedad (DRE) aparece en un 23% de los pacientes ingresados, produciendo un claro aumento de la morbimortalidad de los pacientes.\n\nEn esta serie de libros/foros se incluyen una serie de casos clínicos que repasan diferentes patologías que producen situaciones de desnutrición o riesgo nutricional en pacientes con DM2. Las publicaciones nacen de la experiencia de unas jornadas de casos clínicos patrocinados por laboratorios PERSAN FARMA en varias localizaciones de nuestro país que han permitido poner en común diferentes aspectos de la valoración nutricional, soporte nutricional avanzado y uso de fórmulas específicas para el paciente con DM2. En las jornadas realizadas en Castilla y León se revisaron casos relacionados con la diabetes mellitus tipo 1, trastornos del comportamiento alimentario y pancreatitis aguda.\n\nEn un mundo interconectado con una generación de conocimiento que no nos permite \"digerir\" toda la información relevante que aparece, estas obra tratan de sintetizar de manera clara y práctica a modo de casos clínicos resueltos, el abordaje de diferentes patologías de elevada complejidad, en las que las Guías de Práctica Clínica a veces no se han posicionado de manera clara o existen dudas razonables en el abordaje diagnóstico y terapéutico nutricional. Deseamos que este manual os sea útil para el abordaje diario de vuestros pacientes.\n---\n# Caso Clínico\n\n## Trastorno del comportamiento alimentario en paciente DM1\n\nDra. Ana Isabel Sánchez Marcos\n\nMédico Especialista en Endocrinología y Nutrición.\nUnidad de Trastornos del Comportamiento Alimentario del Complejo Asistencial Universitario\nde Salamanca (UTCA-CAUSA).\n\n### Resumen\n\nLos pacientes con diabetes tipo 1 (DM1), especialmente las mujeres jóvenes, tienen un riesgo 2,4 veces mayor de padecer trastornos del comportamiento alimentario (TCA) que sus pares no diabéticas. Tanto algunos síntomas de la DM1 como aspectos su tratamiento son factores de riesgo para desarrollar TCA. El caso que presentamos es una mujer de 14 años en el momento de la primera consulta, con DM1 desde los 8 años en la que la aparición del TCA supone un punto de inflexión tanto en el control de su enfermedad diabética como en la estabilidad de su situación nutricional. Estas pacientes suponen un reto para el clínico que debe sospechar precozmente el problema, aunque las herramientas de screening\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}